NOVARTIS Archives

IRA: Are Patients Winning at the Cost of the US Pharma Sectoral Growth?

20/06/2024by EOS Intelligence

The market reaction to the US Inflation Reduction Act of 2022 is mostly mixed. It is expected to change the pharma industry dynamics in terms of the competitive positioning and...

An Era of Innovation: Novel Drugs Redefining Multiple Sclerosis Treatment Paradigm

30/05/2024by EOS Intelligence

Since the approval of the first drug, interferon beta 1b (IFNβ-1b), in 1993, the treatment landscape of multiple sclerosis (MS) has significantly changed. Currently, there exist more than 20 disease-modifying...

Will Pharma Tweet Louder? 6 Rules of Doing it Right on Social Media

23/05/2013by EOS Intelligence

Initially considered to be exclusively a tool for common people to connect with friends and share their private pictures, social media platforms have now gained the status of a potent...

Who We Are

Connect With Us

Work With EOS

Who We Are

Connect With Us

Work With EOS

NOVARTIS

An Era of Innovation: Novel Drugs Redefining Multiple Sclerosis Treatment Paradigm